Due Diligence Costs for Pharmaceutical In-Licensing Deals Topping $6 Million RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 29, 2011) - The cost of conducting due diligence for a large or complex pharmaceutical in-licensing deal can run as high as $6 million, though the...

Net-Present Value Still a Top Priority for Pharmaceutical In-Licensing Deals RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 21, 2011) - When evaluating a deal's potential profitability, pharmaceutical business development and licensing teams use similar criteria regardless of...